# Neuroendocrine crosstalk between sex and metabolic hormones: mechanisms and implications across the female reproductive spectrum

**Authors:** Virginie Goulet, Dali Léveillé, Jimeng Li, Alexandre Fisette

PMC · DOI: 10.1007/s44417-026-00014-7 · 2026-02-04

## TL;DR

The paper explores how sex and metabolic hormones work together in the brain to regulate energy and fertility in women across their reproductive lives.

## Contribution

It highlights new insights into how estradiol interacts with metabolic hormones through shared pathways and how these interactions change during menopause and pregnancy.

## Key findings

- Estradiol enhances metabolic hormone signaling via pathways like PI3K/Akt and JAK/STAT.
- Menopause disrupts hormonal crosstalk, leading to metabolic imbalances like insulin resistance.
- Pregnancy increases hormonal coordination to meet fetal energy needs but can lead to disorders like gestational diabetes.

## Abstract

Energy metabolism and fertility are intricately linked across the female lifespan, from puberty through pregnancy, lactation, and menopause, ensuring that nutrition aligns with reproductive demands. We review here the nature of the synergistic crosstalk between sex hormones (notably estradiol) and metabolic hormones (including insulin, leptin, adiponectin, GLP‑1, ghrelin) within the brain, across the female reproductive spectrum. Estradiol amplifies metabolic signaling via shared pathways such as PI3K/Akt and JAK/STAT and enhances receptor sensitivity and secretion of multiple metabolic hormones, supporting the regulation of appetite, energy expenditure, and glucose homeostasis. Menopause disrupts this integrated network as estradiol declines, resulting in metabolic imbalances characterized by impaired hormone sensitivity, weight gain, and insulin resistance. In contrast, pregnancy enhances hormonal crosstalk through placental hormones, triggering metabolic realignments necessary for fetal energy demands. However, excessive or dysregulated adaptations may contribute to disorders like gestational diabetes. Understanding these synergies, and how estrogen receptor-associated co‑transcription factors can modulate them, represents a promising therapeutic direction to restore metabolic and reproductive health during hormonal transitions such as menopause and pregnancy.

## Linked entities

- **Proteins:** LOC116920926 (17-beta-hydroxysteroid dehydrogenase type 6), PIN (insulin precursor), lepa (leptin a), GCG (glucagon), GHRL (ghrelin and obestatin prepropeptide), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), jak (Janus kinase), SOAT1 (sterol O-acyltransferase 1)
- **Diseases:** gestational diabetes (MONDO:0005406)

## Full-text entities

- **Genes:** ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}
- **Diseases:** insulin resistance (MESH:D007333), gestational diabetes (MESH:D016640), metabolic (MESH:D008659), weight gain (MESH:D015430)
- **Chemicals:** glucose (MESH:D005947), Estradiol (MESH:D004958)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872743/full.md

---
Source: https://tomesphere.com/paper/PMC12872743